About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Invest
- Investor Centre
- Media Centre
Contact

Hit enter to search or ESC to close

Phosphagenics Initiates Arbitration Against Mylan

January 7, 2016

Click here to read more

Post navigation

Phosphagenics’ PHN Trial Completes Enrolment and Dosing

Phosphagenics Reports Positive Resuls for Weaner Pig Efficiency Trial

Related Posts

Phosphagenics Signs Non-Binding Term Sheet for Oxymorphone Patch in Japan

January 31, 2017

Quarterly Shareholder Update

July 1, 2015

Ashland Purchases Manufacturing Rights for VitalET and TPM

June 20, 2019August 28, 2019

Recent Posts

Watch now: how significant is chronic insomnia in Australia?
October 14, 2026
Recruitent recommences for phase III insomnia trial
August 31, 2026
Euroz Hartleys | Successful Phase 3 Interim Results
July 8, 2026

Categories

Analyst Coverage
Company Announcement
Company Report
Investor Webinar
Media Coverage
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

Leave this field empty if you're human:

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- Media Centre

© Copyright 2019 Avecho Biotechnology Ltd.